CA
KERX

Centerpoint Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Centerpoint Advisors’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,500
Closed -$29K – 279
2018
Q3 		$29K Hold
8,500
– – 0.02% 118
2018
Q2 		$32K Hold
8,500
– – 0.03% 118
2018
Q1 		$35K Hold
8,500
– – 0.03% 109
2017
Q4 		$40K Buy
+8,500
New +$40K 0.04% 86